Administration of gonadotropin-releasing hormone antagonist from day 1 of stimulation in in vitro fertilization

被引：14
|
作者：
Kolibianakis, EM [1 ]
Zikopoulos, K [1 ]
Smitz, J [1 ]
Camus, M [1 ]
Tournaye, H [1 ]
Van Steirteghem, AC [1 ]
Devroey, P [1 ]
机构：
[1] Free Univ Brussels, Ctr Reprod Med, B-1090 Brussels, Belgium
来源：
FERTILITY AND STERILITY | 2004年 / 82卷 / 01期
关键词：
D O I：
10.1016/j.fertnstert.2003.12.027
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
After administration of GnRH antagonist from day I of stimulation for IVF, 12.1 cumulus oocyte complexes were retrieved (95% confidence interval [CI], 10.6-13.6), 1.9 embryos were transferred (95% CI, 1.7-2.0), and 2.4 embryos were cryopreserved (95% CI, 1.7-3.1). Stimulation for 8.8 days (95% CI, 8.4-9.2) with recombinant FSH resulted in an ongoing implantation rate of 26.5% (95% Cl, 17.1-35.9) and an ongoing pregnancy rate of 39.7% per started cycle (95% Cl, 30.1-50.8) and of 42.4% per ET (95% CI, 32.3-53.1).
引用
收藏
页码：223 / 226
页数：4
相关论文
共 50 条
  • [41] Fine tuning cycle day 3 hormonal assessment of ovarian reserve improves in vitro fertilization outcome in gonadotropin-releasing hormone antagonist cycles
    Jurema, MW
    Bracero, NJ
    Garcia, JE
    FERTILITY AND STERILITY, 2003, 80 (05) : 1156 - 1161
  • [42] Follicular growth and development under continuous gonadotropin-releasing hormone antagonist administration
    Weissman, Ariel
    Ravhon, Amir
    Biran, Galia
    Levin, Dan
    Golan, Abraham
    Levran, David
    FERTILITY AND STERILITY, 2007, 88 (06) : 1677.e15 - 1677.e17
  • [43] A pilot study involving minimal ovarian stimulation for in vitro fertilization: extending the "follicle-stimulating hormone window" combined with the gonadotropin-releasing hormone antagonist cetrorelix
    de Jong, D
    Macklon, NS
    Fauser, BCJM
    FERTILITY AND STERILITY, 2000, 73 (05) : 1051 - 1054
  • [44] PULSATILE ADMINISTRATION OF GONADOTROPIN-RELEASING HORMONE AGONIST TO GILTS ACTIVELY IMMUNIZED AGAINST GONADOTROPIN-RELEASING HORMONE
    TRAYWICK, GB
    ESBENSHADE, KL
    JOURNAL OF ANIMAL SCIENCE, 1988, 66 (09) : 2209 - 2215
  • [45] Midluteal buserelin is superior to early follicular phase buserelin in combined gonadotropin-releasing hormone analog and gonadotropin stimulation in in vitro fertilization
    Urbancsek, J
    Witthaus, E
    FERTILITY AND STERILITY, 1996, 65 (05) : 966 - 971
  • [46] Sperm to zona pellucida binding depends on the use of a gonadotropin-releasing hormone agonist or a gonadotropin-releasing hormone antagonist
    Schröder, AK
    Schöpper, B
    Al-Hasani, S
    Löning, M
    Diedrich, K
    Ludwig, M
    FERTILITY AND STERILITY, 2003, 79 (03) : 648 - 650
  • [47] Model of gonadotropin-releasing hormone and gonadotropin-releasing hormone complex
    Wiwanitkit, Viroj
    SEXUALITY AND DISABILITY, 2006, 24 (03) : 175 - 178
  • [48] Low-dose human chorionic gonadotropin may improve in vitro fertilization cycle outcomes in patients with low luteinizing hormone levels after gonadotropin-releasing hormone antagonist administration
    Propst, Anthony M.
    Hill, Micah J.
    Bates, Gordon Wright
    Palumbo, Michelle
    Van Horne, Anne K.
    Retzloff, Matthew G.
    FERTILITY AND STERILITY, 2011, 96 (04) : 898 - 904
  • [49] Effect of a low dose of gonadotropin releasing hormone antagonist on in vitro fertilization outcomes
    Özlem Seçilmiş Kerimoğlu
    Cihangir Mutlu Ercan
    Uğur Keskin
    Cem Korkmaz
    Namık Kemal Duru
    Ali Ergün
    Archives of Gynecology and Obstetrics, 2013, 288 : 691 - 695
  • [50] Model of gonadotropin-releasing hormone and gonadotropin-releasing hormone complex
    Viroj Wiwanitkit
    Sexuality and Disability, 2006, 24 : 175 - 178
12345